These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 23010271
1. Novel cyanocombretastatins as potent tubulin polymerisation inhibitors. Jalily PH, Hadfield JA, Hirst N, Rossington SB. Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6731-4. PubMed ID: 23010271 [Abstract] [Full Text] [Related]
2. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors. Romagnoli R, Oliva P, Salvador MK, Camacho ME, Padroni C, Brancale A, Ferla S, Hamel E, Ronca R, Grillo E, Bortolozzi R, Rruga F, Mariotto E, Viola G. Eur J Med Chem; 2019 Nov 01; 181():111577. PubMed ID: 31400707 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of double bond substituted combretastatins. Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT. Eur J Med Chem; 2005 Jun 01; 40(6):529-41. PubMed ID: 15922837 [Abstract] [Full Text] [Related]
4. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ. Bioorg Med Chem; 2009 Nov 15; 17(22):7698-710. PubMed ID: 19837593 [Abstract] [Full Text] [Related]
5. Design, synthesis and biological studies of novel tubulin inhibitors. Sun Y, Pandit B, Chettiar SN, Etter JP, Lewis A, Johnsamuel J, Li PK. Bioorg Med Chem Lett; 2013 Aug 01; 23(15):4465-8. PubMed ID: 23790539 [Abstract] [Full Text] [Related]
6. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Nien CY, Chen YC, Kuo CC, Hsieh HP, Chang CY, Wu JS, Wu SY, Liou JP, Chang JY. J Med Chem; 2010 Mar 11; 53(5):2309-13. PubMed ID: 20148562 [Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers. Kamal A, Shaik B, Nayak VL, Nagaraju B, Kapure JS, Shaheer Malik M, Shaik TB, Prasad B. Bioorg Med Chem; 2014 Oct 01; 22(19):5155-67. PubMed ID: 25192811 [Abstract] [Full Text] [Related]
8. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues. Mustafa M, Abdelhamid D, Abdelhafez EMN, Ibrahim MAA, Gamal-Eldeen AM, Aly OM. Eur J Med Chem; 2017 Dec 01; 141():293-305. PubMed ID: 29031074 [Abstract] [Full Text] [Related]
9. Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues. Jedhe GS, Paul D, Gonnade RG, Santra MK, Hamel E, Nguyen TL, Sanjayan GJ. Bioorg Med Chem Lett; 2013 Aug 15; 23(16):4680-4. PubMed ID: 23809851 [Abstract] [Full Text] [Related]
10. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M. Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3417-20. PubMed ID: 17434303 [Abstract] [Full Text] [Related]
11. Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds. Alvarez R, Alvarez C, Mollinedo F, Sierra BG, Medarde M, Peláez R. Bioorg Med Chem; 2009 Sep 01; 17(17):6422-31. PubMed ID: 19647439 [Abstract] [Full Text] [Related]
12. Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues. Wen Z, Li X, Zuo D, Lang B, Wu Y, Jiang M, Ma H, Bao K, Wu Y, Zhang W. Sci Rep; 2016 Apr 05; 6():23986. PubMed ID: 27045272 [Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of 2-amino-7,7-dimethyl 4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents. Alqasoumi SI, Al-Taweel AM, Alafeefy AM, Hamed MM, Noaman E, Ghorab MM. Bioorg Med Chem Lett; 2009 Dec 15; 19(24):6939-42. PubMed ID: 19879135 [Abstract] [Full Text] [Related]
14. Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization. Provot O, Hamze A, Peyrat JF, Brion JD, Alami M. Anticancer Agents Med Chem; 2013 Dec 15; 13(10):1614-35. PubMed ID: 24261611 [Abstract] [Full Text] [Related]
15. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells. Álvarez R, Gajate C, Puebla P, Mollinedo F, Medarde M, Peláez R. Eur J Med Chem; 2018 Oct 05; 158():167-183. PubMed ID: 30216850 [Abstract] [Full Text] [Related]
16. Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues. Guan Q, Zuo D, Jiang N, Qi H, Zhai Y, Bai Z, Feng D, Yang L, Jiang M, Bao K, Li C, Wu Y, Zhang W. Bioorg Med Chem Lett; 2015 Feb 01; 25(3):631-4. PubMed ID: 25529737 [Abstract] [Full Text] [Related]
17. Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent. Messaoudi S, Tréguier B, Hamze A, Provot O, Peyrat JF, De Losada JR, Liu JM, Bignon J, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M. J Med Chem; 2009 Jul 23; 52(14):4538-42. PubMed ID: 19530698 [Abstract] [Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents. Sun B, Li L, Hu QW, Zheng HB, Tang H, Niu HM, Yuan HQ, Lou HX. Eur J Med Chem; 2017 Mar 31; 129():186-208. PubMed ID: 28222318 [Abstract] [Full Text] [Related]
19. Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity. Rasolofonjatovo E, Provot O, Hamze A, Rodrigo J, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Alami M. Eur J Med Chem; 2012 Jun 31; 52():22-32. PubMed ID: 22449653 [Abstract] [Full Text] [Related]
20. Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents. Liu YQ, Li XJ, Zhao CY, Nan X, Tian J, Morris-Natschke SL, Zhang ZJ, Yang XM, Yang L, Li LH, Zhou XW, Lee KH. Bioorg Med Chem; 2013 Mar 01; 21(5):1248-56. PubMed ID: 23369687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]